Advancing Health Equity: Designing Inclusive Clinical Trials in Europe

Advancing Health Equity: Designing Inclusive Clinical Trials in Europe

ECRIN Senior Project Manager Paediatric and PPI Specialist Salma Malik was thrilled to present the READI project at the recent DSxHE Data Diversity x READI webinar.

Our session, "Designing Inclusive Clinical Trials: a European Perspective," brought together an incredible community passionate about driving health inclusivity through better data science and inclusive research practices.

During the webinar, Salma highlighted how the READI project is working toward:

• Creating an Inclusive European Clinical Research Ecosystem: Breaking down barriers to ensure clinical research reflects diverse patient populations.
• Patient-Centered Advancements: Operating as an IHI-funded Public-Private Partnership to put patients at the very heart of clinical trial design.
• Collaborative Innovation: Bringing together industry leaders, academic institutions, and regulatory bodies to harmonize inclusivity and representativness goals across Europe.

Putting Patients in the Driver’s Seat of Clinical Research

Europe’s population presents a rich variety of societal and environmental influence across multiple countries and includes heterogeneous demographic and genetic profiles. Yet, current EU clinical research does not fully reflect this reality.
The READI project is here to change that. As she shared during the webinar, READI aims to put patients in the driver’s seat as active partners, not an afterthought.

READI aims to transform the clinical research ecosystem and capabilities, with patients at the centre, and key stakeholders working together for more inclusive clinical studies in Europe.

Clinical trials need to reflect the real world

Speakers also highlighted the vital mission driving the READI project: "Our goal is to open the door wider, include more voices, and build studies that represent the people who actually use the treatments."

For too long, clinical research has missed crucial perspectives. To create treatments that work safely and effectively for everyone, we must transform how studies are designed to be truly inclusive and representative.

Future goals include:

• Breaking down barriers to trial participation
• Improving inclusion of underrepresented populations
• Increasing awareness of inclusive clinical research
• Making clinical studies genuinely accessible and representative 

A huge thank you to Data Science for Health Equity (DSxHE) and Cancer Research UK for hosting such an important conversation. We look forward to building a more inclusive healthcare ecosystem, together.